INABIN8BIO, INC.vs its industry peers
A metric-by-metric comparison of IN8BIO, INC. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INABThis | $9M#6 | — | 0.5x#1 | — | — | 36.1%#1 | — | -105.9%#1 | — | — | -48.9%#3 | — |
| PLUR | $15M#1 | — | — | 15.1x#1 | -24.0%#1 | -5.5%#6 | -2454.5%#1 | — | — | — | -68.9%#5 | — |
| BCDA | $14M#2 | — | 5.3x#4 | — | -100.0%#2 | -3.5%#5 | — | -304.7%#3 | — | — | -33.2%#2 | — |
| BCLI | $13M#3 | — | — | — | — | 11.3%#4 | — | — | — | — | -1.7%#1 | — |
| PASG | $12M#4 | — | 2.6x#3 | — | — | 29.7%#2 | — | -1021.6%#4 | — | — | -50.3%#4 | — |
| INTS | $11M#5 | — | 1.2x#2 | — | — | 28.7%#3 | — | -126.0%#2 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice